A R T I C L E S
Nolan and Lippard
Scheme 1. Synthesis of MS5 and Its Salicylaldehyde-Based Analogue L
Although we encountered no problems with the isolated compounds,
all due precautions should be taken.
an orange oil. Chromatography on Al2O3 with a solvent gradient (2:1
hexanes/EtOAc to 100% EtOAc) afforded the product as an orange oil
that solidified upon cooling at 4 °C (812 mg, 65%): TLC Rf ) 0.60
(Al2O3, 2:1 hexanes/EtOAc); 1H NMR (CDCl3, 300 MHz) δ 1.17 (6H,
t), 2.37 (4H, q), 2.58 (4H, m), 2.65 (4H, m), 3.70 (2H, s), 4.48 (2H, s),
6.78-6.91 (4H, m), 7.05 (1H, dd), 7.16-7.23 (3H, m); 13C NMR
(CDCl3, 125 MHz) δ 14.79, 25.88, 29.34, 47.65, 53.02, 58.35, 113.18,
116.33, 119.25, 119.75, 123.64, 124.72, 128.57, 128.90, 130.29, 147.42,
157.16; FTIR (NaCl disk, cm-1) 3217 (s, br), 3043 (s), 2963 (s), 2924
(s), 2869 (s), 2845 (s), 2817 (s), 2717 (w), 1606 (s), 1588 (s), 1508
(s), 1490 (s), 1455 (s), 1375 (m), 1314 (m), 1294 (m), 1250 (m), 1149
(w), 1119 (m), 1102 (m), 1050 (m), 1036 (m), 983 (m), 932 (m), 855
(m), 839 (m), 753 (s), 723 (m), 659 (w), 629 (w), 565 (w), 531 (w);
HRMS (ESI) calcd, 405.2029 ([M + H]+), found 405.2019.
[Hg(L)](ClO4)2‚CH3OH (6). A portion (9.7 mg, 0.024 mmol) of
Hg(ClO4)2‚H2O was suspended in 0.5 mL of MeOH, to which a solution
of 5 (10 mg, 0.025 mmol) in 0.5 mL of MeOH was added dropwise as
the solution turned yellow. The solution was sonicated for 5 min and
filtered. Colorless, thin needle crystals suitable for X-ray crystal-
lographic analysis formed over the course of 48 h by vapor diffusion
of Et2O into the reaction at room temperature. The solvents were
decanted, and the crystals were washed with Et2O (4 × 3 mL) and
dried in vacuo (11.5 mg, 48%): FTIR (KBr, cm-1) 3546 (m, br), 3192
(m, br), 3069 (w), 2969 (w), 2932 (w), 2865 (w), 2835 (w), 2700 (w),
2605 (w), 2552 (w), 1609 (m), 1594 (m), 1496 (m), 1460 (s), 1421
(m), 1384 (m), 1368 (m), 1300 (w), 1258 (m), 1218 (w), 1188 (w),
1102 (s, br), 1084 (s), 1055 (s), 1047 (s), 1004 (m), 932 (m), 922 (m),
910 (m), 884 (m), 870 (m), 853 (m), 832 (w), 801 (w), 770 (s), 729
(w), 717 (m), 672 (w), 622 (s), 575 (w), 543 (w), 521 (w), 494 (w),
484 (w), 468 (w); HRMS (ESI) calcd 605.1584 ([M -2(ClO4) - H]+),
found 605.1578. Anal. Calcd for C23H36Cl2N2O10S2Hg: C, 33.04; H,
4.34; N, 3.35. Found: C, 33.01; H, 4.44; N, 3.30.
Materials and Methods. Merck 254 silica gel 60 plates (0.25 mm
thickness) were used for analytical TLC and were viewed with UV
light. Whatman silica gel 60 plates (1 mm thickness) were used as the
solid phase for preparative TLC. NMR spectra were collected on a
Varian 300 or 500 MHz spectrophotometer, and the spectra were
referenced to internal standards. An Avatar FTIR instrument was used
to obtain IR spectra. High-resolution mass spectra were collected by
staff at the MIT Department of Chemistry Instrumentation Facility.
2-{11-[(2-{[Bis-(2-ethylsulfanylethyl)amino]methyl}phenylamino)-
methyl]-3-hydroxy-10-oxo-10H-benzo[c]xanthen-7-yl}benzoic Acid
(4, MS5). To 9 mL of a 7:2 CHCl3/MeOH mixture were added 1 (71
mg, 0.17 mmol) and 2 (52 mg, 0.17 mmol), which gave a red-brown
solution that was stirred at room temperature. After 24 h, 3 mL of
DCE and NaB(OAc)3H (40 mg, 0.19 mmol) were added, and the
reaction was stirred for an additional 24 h, during which time it became
wine-colored. The solvents were removed under reduced pressure, and
preparative TLC on silica gel (20:1 CHCl3/MeOH) yielded pure MS5
as a purple solid (38 mg, 32%): TLC Rf ) 0.64 (9:1 CHCl3/MeOH);
1
mp >300 °C dec; H NMR (CD3OD, 500 MHz) δ 0.94 (6H, t), 2.08
(4H, m), 2.24 (4H, m), 2.39 (2H, m), 2.47 (2H, m), 3.55 (2H, s), 4.70
(2H, q), 6.64 (1H, t), 6.71 (1H, d), 6.92 (1H, d), 6.98 (3H, m), 7.13
(1H, d), 7.20 (1H, d), 7.28 (2H, m), 7.34 (1H, m), 7.61 (2H, m), 8.10
(1H, d), 8.27 (1H, m); FTIR (KBr, cm-1) 3428 (w, br), 3052 (w), 2957
(w), 2921 (w), 2857 (w), 2800 (w), 1752 (w), 1641 (m), 1600 (s), 1585
(s), 1563 (m), 1504 (m), 1470 (s), 1443 (s), 1377 (m), 1339 (m), 1309
(m), 1251 (m), 1143 (m), 1091 (m), 1070 (w), 1046 (w), 1004 (w),
961 (w), 931 (w), 877 (w), 862 (w), 827 (w), 789 (w), 748 (w), 726
(w), 704 (w), 678 (w), 643 (w), 613 (w), 596 (w), 526 (w), 448 (w);
HRMS (ESI) calc, 691.2306 ([M - H]-), found 691.2325.
2-[(2-{[Bis-(2-ethylsulfanylethyl)amine]methyl}phenylamine)-
methyl]phenol (5, L). Salicylaldehyde (376 mg, 3.08 mmol) and N-(2-
aminobenzyl)-3,9-dithia-6-azaundecane (1, 914 mg, 3.07 mmol) were
combined in 40 mL of EtOAc and stirred for 10 h at room temperature.
The solvent was removed in vacuo to yield an orange-yellow oil. The
oil was dissolved in 30 mL of DCE, and NaB(OAc)3H (700 mg, 3.33
mmol) was added. The reaction was stirred overnight at room
temperature, diluted with 40 mL of dichloromethane, and washed with
saturated brine (3 × 80 mL) and then water (1 × 80 mL). The organic
portion was dried over MgSO4, and the solvent was removed to yield
[Hg(TPEN)](ClO4)2 (7). A portion (7.8 mg, 0.195 mmol) of
Hg(ClO4)2‚H2O in 1 mL of MeOH was added dropwise to a solution
of TPEN (7.9 mg, 0.184 mmol) in 1 mL of MeOH. The solution was
mixed with a pipet and filtered. Colorless rodlike crystals suitable for
X-ray crystallography formed over the course of 48 h from vapor
diffusion of Et2O into the reaction mixture at room temperature. The
solvents were decanted, and the crystals were washed with Et2O (4 ×
3 mL) and dried in vacuo (8.6 mg, 57%): FTIR (KBr, cm-1) 3107
(w), 3078 (w), 3033 (w), 2963 (w), 2937 (w), 2911 (w), 2895 (w),
9
5912 J. AM. CHEM. SOC. VOL. 129, NO. 18, 2007